Skip to content

Open data

Peptide statistics 2026

24 numbers on the 67 peptides and related compounds we track, each computed in code from the records and dated. Link to any number, or copy its citation.

Data as of . Part of the Peptide Evidence Index. License CC BY 4.0.

What the dataset covers

67

The dataset covers 67 peptides and related compounds (6 of them blends), each with sourced dosing, side effects, storage and regulatory status.

How: Count of validated compound records in data/peptides. The breakdown counts category tags; a compound can carry several.

Breakdown: The dataset covers 67 peptides and related compounds (6 of them blends), each with sourced dosing, side effects, storage and regulatory status.
Weight loss15
Cognitive14
Longevity13
GH axis12
Healing & recovery12
Skin & hair8
GLP-17
Immune7
Sexual health5
Sleep5
Other4
Link to this number

100%

67 of 67 compounds (100%) have community findings mined from Reddit dose reports.

How: Compounds with a data/community/<slug>.json file from the monthly Reddit mining job.

Link to this number

34,824

34,824 Reddit posts and comments were read for dose, frequency and side-effect reports, out of 121,872 that mention a covered compound.

How: Sum of corpus.analyzed (items read by the extractor, capped per compound) and corpus.relevant (items about the compound and its use) across community files.

Link to this number

Human evidence

35.8%

24 of 67 compounds (35.8%) have no completed human trial on record.

How: Compounds whose evidenceSummary.humanTrials is "none".

Link to this number

23.9%

For 16 of 67 compounds (23.9%), the only published evidence comes from animal or cell studies.

How: Compounds whose evidenceSummary.animalOnly is true.

Link to this number

67

Human trial evidence by compound: 24 none, 22 limited, 10 moderate, 11 strong.

How: Count of compounds per evidenceSummary.humanTrials level (none, limited, moderate, strong).

Breakdown: Human trial evidence by compound: 24 none, 22 limited, 10 moderate, 11 strong.
No human trials24
Limited22
Strong11
Moderate10
Link to this number

FDA status and sport

14.9%

10 of 67 compounds (14.9%) are FDA-approved for any use.

How: Compounds with fdaStatus approved or approved_other_indication, from Drugs@FDA and FDA labels.

Link to this number

7

7 compounds are FDA-approved only for a narrower use than the one people take them for.

How: Compounds with fdaStatus approved_other_indication.

Link to this number

67

FDA status across the dataset: 3 approved, 7 approved other indication, 3 compounding category 1, 3 compounding category 2, 1 compounding category 3, 7 investigational, 20 not evaluated, 23 removed or withdrawn.

How: Count of compounds per fdaStatus.status, each backed by FDA's own pages (503A/503B category lists, safety-risk page, Drugs@FDA, Federal Register).

Breakdown: FDA status across the dataset: 3 approved, 7 approved other indication, 3 compounding category 1, 3 compounding category 2, 1 compounding category 3, 7 investigational, 20 not evaluated, 23 removed or withdrawn.
Removed or withdrawn23
Not evaluated20
Approved for another use7
In trials7
503A Category 13
503A Category 23
Approved3
503A Category 31
Link to this number

29.9%

20 of 67 compounds (29.9%) appear on no FDA approval record, compounding category list or compounding safety-risk list.

How: Compounds with fdaStatus not_evaluated: checked against Drugs@FDA, the 503A and 503B category lists and FDA's safety-risk page.

Link to this number

38.8%

26 of 67 compounds (38.8%) are banned in sport by name or by a class the WADA Prohibited List names.

How: Compounds with regulatoryStatus.wadaProhibited true. Compounds that only the S0 catch-all might cover are counted as unknown, not banned.

Link to this number

Where the doses come from

818

The dataset records 818 dose protocols in circulation, each labelled by where it came from.

How: Count of dosing entries across compounds. Each protocol's origin is the weakest origin among its sources.

Breakdown: The dataset records 818 dose protocols in circulation, each labelled by where it came from.
Competitor guide397
Community-reported239
Clinical study124
Regulatory44
Vendor guide12
Media report1
Reference work1
Link to this number

20.5%

Only 168 of 818 dose protocols (20.5%) come from a clinical study or a regulator's label.

How: Protocols whose origin is clinical_study or regulatory.

Link to this number

29.2%

239 of 818 dose protocols (29.2%) are community-reported: what users say they take.

How: Protocols whose origin is community.

Link to this number

50.2%

411 of 818 dose protocols (50.2%) come from guides, vendor pages, reference sites or the press.

How: Protocols whose origin is competitor_guide, vendor_guide, reference or media.

Link to this number

43.3%

29 of 67 compounds (43.3%) have no dose from any clinical study or label: every dose in circulation comes from users, guides or sellers.

How: Compounds with no dosing entry of origin clinical_study or regulatory.

Link to this number

14

Across the 12 healing and recovery compounds, 147 dose protocols circulate and 14 of them come from a clinical study or regulator.

How: Protocols of compounds tagged healing_recovery, and how many have origin clinical_study or regulatory.

Link to this number

50%

For GLP-1 compounds, 38 of 76 dose protocols (50%) come from a clinical study or label, the highest share of any group.

How: Protocols of compounds tagged glp1 with origin clinical_study or regulatory.

Link to this number

Side effects and warnings

29.9%

195 of 652 recorded side effects (29.9%) are known only from community reports, not from a study or label.

How: Side-effect entries whose origin is community.

Link to this number

202

The dataset lists 202 sourced "avoid with" warnings: substances and conditions that sources say do not mix with a compound.

How: Count of avoidWith entries across compounds.

Link to this number

22

For 22 compounds, published sources give conflicting half-lives, and the dataset shows each figure with its source.

How: Compounds whose halfLife is a list of more than one sourced report.

Link to this number

Sources

2,113

The compound records cite 2,113 distinct source pages from 279 publishers.

How: Distinct source URLs across compound records (community findings pages excluded), and distinct publisher names. The breakdown counts URLs by origin.

Breakdown: The compound records cite 2,113 distinct source pages from 279 publishers.
Community-reported781
Competitor guide523
Clinical study467
Regulatory188
Vendor guide93
Reference work45
Media report16
Link to this number

28.2%

596 of 2,113 cited pages (28.2%) are primary: the study, trial registry, label or regulator's own page.

How: Distinct source URLs with origin clinical_study or regulatory and no quotedVia (read first-hand, not via a news, guide or reference page).

Link to this number

32

The median compound page cites 32 distinct sources.

How: Median over compounds of the number of distinct source URLs in each record.

Link to this number

How it is counted

Each number carries its own method line. The file behind this page is rebuilt from the dataset whenever it changes; 2026-10-24 is the newest record date it counts.

Every number on this page is computed in code from the same records that build our peptide pages; no model writes one. Full rules on the methodology page, and the whole dataset is free to download.

Licensed CC BY 4.0. Reuse any number, including in commercial work. Credit “TruePeptideSource” and link to this page.

Cite this dataset

TruePeptideSource. (2026). Peptide statistics 2026 (Peptide Evidence Index, version 2026-10-24) [Data set]. https://truepeptidesource.com/data/peptide-statistics-2026